“Stick or Twist?” Negotiating Price and Data in an Era of Conditional Approval
Abstract
BackgroundChanges in the regulatory context enable faster approval of transformative medicines. They also lead to health technology assessment (HTA) agencies having to make decisions with less evidence. In response, HTA agencies have also initiated forms of conditional approval. When the evidence base for a new oncology treatment leaves substantial uncertainty, the new Cancer Drugs Fund allows the National Institute for Heath and Care Excellence...
Paper Details
Title
“Stick or Twist?” Negotiating Price and Data in an Era of Conditional Approval
Published Date
Feb 1, 2020
Journal
Volume
23
Issue
2
Pages
191 - 199
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History